Immunomic Therapeutics Revenue

Biotechnology Research • Rockville, Maryland, United States • 21-50 Employees

Immunomic Therapeutics revenue & valuation

Annual revenue	$5,000,000
Revenue per employee	$228,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$16,000,000
Total funding	$70,800,000

Key Contacts at Immunomic Therapeutics

Prakash Koodathingal

Director, Rna Therapeutic Development

Wei Shen

Associate Director, Vaccine Discovery Of Research And Development

Yoseph Kuh

Fp&A Director

Claire Buchta Rosean

Associate Director, Translational Research

Dong-Gun Kim

Chief Executive Officer

Company overview

Headquarters	15010 Broschart Road Suite 250, Rockville, MD 20850, US
Phone number	+13019683501
Website	immunomix.com
SIC	283
Keywords	Lamp Technology, Oncology, Animal Health, Infectious Diseases, Allergy, Dna Vaccines
Founded	2005
Employees	21-50
Socials

Immunomic Therapeutics Email Formats

Immunomic Therapeutics uses 2 email formats. The most common is {first initial}{last name} (e.g., jdoe@immunomix.com), used 87.5% of the time.

Format	Example	Percentage
{first initial}{last name}	jdoe@immunomix.com	87.5%
{first name}{last name}	johndoe@immunomix.com	12.5%

About Immunomic Therapeutics

Immunomic Therapeutics, Inc. (ITI) is a privately-held clinical stage biotechnology company pioneering the study of the Universal Intracellular Targeted Expression (UNITE) nucleic acid immunotherapy platform. This investigational technology has the potential to alter how we use immunotherapy for a number of diseases, including cancer, allergy and infectious diseases.

Employees by Management Level

Total employees: 21-50

Seniority

Employees

Director

Entry

Manager

Employees by Department

Immunomic Therapeutics has 9 employees across 6 departments.

Departments

Number of employees

Funding Data

Explore Immunomic Therapeutics's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount
2020-05-23	19	$61,300,000
2024-05-10	1	$3,000,000
2025-07-02	1	$6,500,000

Funding Insights

$70,800,000

Total funding amount

$6,500,000

Most recent funding amount

Number of funding rounds

Immunomic Therapeutics Tech Stack

Discover the technologies and tools that power Immunomic Therapeutics's digital infrastructure, from frameworks to analytics platforms.

Modernizr

JavaScript libraries

SiteGround

Hosting

PWA

Miscellaneous

lit-element

JavaScript libraries

jQuery UI

JavaScript libraries

Google Maps

Maps

lit-html

JavaScript libraries

Microsoft 365

jQuery Migrate

JavaScript libraries

Cloudflare

CDN

Plyr

Video players

Twitter Emoji

Font scripts

Frequently asked questions

Immunomic Therapeutics is located in Rockville, Maryland, US.

You can reach Immunomic Therapeutics at +13019683501.

Immunomic Therapeutics generates an estimated annual revenue of $5,000,000. This revenue figure reflects the company's market position and business performance in its industry.

Immunomic Therapeutics has an estimated valuation of $16,000,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

Immunomic Therapeutics was founded in 2005, making it 21 years old. The company has established itself as a significant player in its industry over this time.

Immunomic Therapeutics has approximately 21-50 employees. The company continues to grow its workforce to support its business operations and expansion.

Immunomic Therapeutics has raised a total of $70,800,000 across 3 funding rounds. This investment has helped the company grow and expand its operations.

Key Contacts at Immunomic Therapeutics

Prakash Koodathingal

Director, Rna Therapeutic Development

Wei Shen

Associate Director, Vaccine Discovery Of Research And Development

Yoseph Kuh

Fp&A Director

Claire Buchta Rosean

Associate Director, Translational Research

Dong-Gun Kim

Chief Executive Officer

4.8